Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2022

04-01-2022 | Colorectal Cancer | Original Article

Clinical Significance of Surgical Resection Timing from Endoscopic Stenting for Left-Sided Large-Bowel Obstruction in Colorectal Cancer

Authors: Sunseok Yoon, Guangzhe Pian, Sun Gyo Lim, Seung Yeop Oh

Published in: Digestive Diseases and Sciences | Issue 10/2022

Login to get access

Abstract

Background

The optimal interval between self-expanding metallic stent (SEMS) insertion and surgery remains controversial in malignant left-sided large-bowel obstruction (MLLO), especially with respect to oncologic aspects.

Aims

The aim of this study is to examine whether the time interval to surgery is related to oncologic outcomes.

Methods

Prospectively collected database of MLLO between January 2005 and December 2017 were reviewed. They were divided according to established cut-off value of 14 days for the time interval to surgery. The two groups (early and late groups) were compared with respect to disease-free survival (DFS) and overall survival (OS). Additional subgroup analysis was performed using the established cut-off values for patients with stage II and III tumors.

Results

A total of 149 patients underwent surgery after SEMS insertion. There were no significant differences between the early and late groups in the 5-year DFS (78.0% vs 72.4%; P = 0.513) and the OS (74.2% vs 75.7%; P = 0.864) rates in all MLLO. Subgroup analysis showed that there were significant differences between the two groups for DFS and OS in stage II MLLO. The multivariate Cox regression analysis in stage II MLLO demonstrated that the time to surgery was a prognostic factor for DFS (HR, 2.051; 95% CI, 1.528–42.136; P = 0.014) and for OS (HR, 4.947; 95% CI, 1.520–16.107; P = 0.008).

Conclusions

The time to surgery was demonstrated not to be a significant prognostic factor in all MLLO. However, it was a prognostic factor for patients with stage II MLLO.
Literature
1.
go back to reference Deans GT, Krukowski ZH, Irwin ST. Malignant obstruction of the left colon. Br J Surg 1994;81:1270–1276.CrossRef Deans GT, Krukowski ZH, Irwin ST. Malignant obstruction of the left colon. Br J Surg 1994;81:1270–1276.CrossRef
2.
go back to reference Dohmoto M, Rupp KD, Hohlbach G. Endoscopically-implanted prosthesis in rectal carcinoma. Dtsch Med Wochenschr 1990;115:915.PubMed Dohmoto M, Rupp KD, Hohlbach G. Endoscopically-implanted prosthesis in rectal carcinoma. Dtsch Med Wochenschr 1990;115:915.PubMed
3.
go back to reference Tejero E, Mainar A, Fernández L et al. New procedure for the treatment of colorectal neoplastic obstructions. Dis Colon Rectum 1994;37:1158–1159.CrossRef Tejero E, Mainar A, Fernández L et al. New procedure for the treatment of colorectal neoplastic obstructions. Dis Colon Rectum 1994;37:1158–1159.CrossRef
4.
go back to reference Cirocchi R, Farinella E, Trastulli S et al. Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis. Surg Oncol 2013;22:14–21.CrossRef Cirocchi R, Farinella E, Trastulli S et al. Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis. Surg Oncol 2013;22:14–21.CrossRef
5.
go back to reference Huang X, Lv B, Zhang S et al. Preoperative colonic stents versus emergency surgery for acute left-sided malignant colonic obstruction: a meta-analysis. J Gastrointest Surg 2014;18:584–591.CrossRef Huang X, Lv B, Zhang S et al. Preoperative colonic stents versus emergency surgery for acute left-sided malignant colonic obstruction: a meta-analysis. J Gastrointest Surg 2014;18:584–591.CrossRef
6.
go back to reference Khot UP, Lang AW, Murali K et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002;89:1096–1102.CrossRef Khot UP, Lang AW, Murali K et al. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002;89:1096–1102.CrossRef
7.
go back to reference Martinez-Santos C, Lobato RF, Fradejas JM et al. Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 2002;45:401–406.CrossRef Martinez-Santos C, Lobato RF, Fradejas JM et al. Self-expandable stent before elective surgery vs. emergency surgery for the treatment of malignant colorectal obstructions: comparison of primary anastomosis and morbidity rates. Dis Colon Rectum 2002;45:401–406.CrossRef
8.
go back to reference Zhang Y, Shi J, Shi B et al. Self-expanding metallic stent as a bridge to surgery versus emergency surgery for obstructive colorectal cancer: a meta-analysis. Surg Endosc 2012;26:110–119.CrossRef Zhang Y, Shi J, Shi B et al. Self-expanding metallic stent as a bridge to surgery versus emergency surgery for obstructive colorectal cancer: a meta-analysis. Surg Endosc 2012;26:110–119.CrossRef
9.
go back to reference van Hooft JE, Veld JV, Arnold D et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020. Endoscopy 2020;52:389–407.CrossRef van Hooft JE, Veld JV, Arnold D et al. Self-expandable metal stents for obstructing colonic and extracolonic cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2020. Endoscopy 2020;52:389–407.CrossRef
10.
go back to reference Koch M, Kienle P, Sauer P et al. Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer. Surg Endosc 2004;18:587–591.CrossRef Koch M, Kienle P, Sauer P et al. Hematogenous tumor cell dissemination during colonoscopy for colorectal cancer. Surg Endosc 2004;18:587–591.CrossRef
11.
go back to reference Lara-Romero C, Vilches Á, Caunedo-Álvarez Á et al. Better recurrence-free survival after stent bridge to surgery compared to emergency surgery for obstructive left-sided colonic cancer in patients with stage III status of the American Joint Committee on Cancer (AJCC): a bicentric retrospective study. Int J Colorectal Dis 2019;34:1241–1250.CrossRef Lara-Romero C, Vilches Á, Caunedo-Álvarez Á et al. Better recurrence-free survival after stent bridge to surgery compared to emergency surgery for obstructive left-sided colonic cancer in patients with stage III status of the American Joint Committee on Cancer (AJCC): a bicentric retrospective study. Int J Colorectal Dis 2019;34:1241–1250.CrossRef
12.
go back to reference Sabbagh C, Browet F, Diouf M et al. Is stenting as “a bridge to surgery” an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis. Ann Surg 2013;258:107–115.CrossRef Sabbagh C, Browet F, Diouf M et al. Is stenting as “a bridge to surgery” an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis. Ann Surg 2013;258:107–115.CrossRef
13.
go back to reference Amelung FJ, Burghgraef TA, Tanis PJ et al. Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer; a systematic review and meta-analysis. Crit Rev Oncol Hematol 2018;131:66–75.CrossRef Amelung FJ, Burghgraef TA, Tanis PJ et al. Critical appraisal of oncological safety of stent as bridge to surgery in left-sided obstructing colon cancer; a systematic review and meta-analysis. Crit Rev Oncol Hematol 2018;131:66–75.CrossRef
14.
go back to reference Matsuda A, Miyashita M, Matsumoto S et al. Optimal interval from placement of a self-expandable metallic stent to surgery in patients with malignant large bowel obstruction: a preliminary study. Surg Laparosc Endosc Percutan Tech 2018;28:239–244.CrossRef Matsuda A, Miyashita M, Matsumoto S et al. Optimal interval from placement of a self-expandable metallic stent to surgery in patients with malignant large bowel obstruction: a preliminary study. Surg Laparosc Endosc Percutan Tech 2018;28:239–244.CrossRef
15.
go back to reference Lee GJ, Kim HJ, Baek JH et al. Comparison of short-term outcomes after elective surgery following endoscopic stent insertion and emergency surgery for obstructive colorectal cancer. Int J Surg 2013;11:442–446.CrossRef Lee GJ, Kim HJ, Baek JH et al. Comparison of short-term outcomes after elective surgery following endoscopic stent insertion and emergency surgery for obstructive colorectal cancer. Int J Surg 2013;11:442–446.CrossRef
16.
go back to reference Lim TZ, Chan DKH, Tan KK. Endoscopic stenting should be advocated in patients with stage IV colorectal cancer presenting with acute obstruction. J Gastrointest Oncol 2018;9:785–790.CrossRef Lim TZ, Chan DKH, Tan KK. Endoscopic stenting should be advocated in patients with stage IV colorectal cancer presenting with acute obstruction. J Gastrointest Oncol 2018;9:785–790.CrossRef
17.
go back to reference Kye BH, Kim JH, Kim HJ et al. The optimal time interval between the placement of self-expandable metallic stent and elective surgery in patients with obstructive colon cancer. Sci Rep 2020;10:9502.CrossRef Kye BH, Kim JH, Kim HJ et al. The optimal time interval between the placement of self-expandable metallic stent and elective surgery in patients with obstructive colon cancer. Sci Rep 2020;10:9502.CrossRef
18.
go back to reference Avlund TH, Erichsen R, Ravn S et al. The prognostic impact of bowel perforation following self-expanding metal stent as a bridge to surgery in colorectal cancer obstruction. Surg Endosc 2018;32:328–336.CrossRef Avlund TH, Erichsen R, Ravn S et al. The prognostic impact of bowel perforation following self-expanding metal stent as a bridge to surgery in colorectal cancer obstruction. Surg Endosc 2018;32:328–336.CrossRef
19.
go back to reference Lee YJ, Yoon JY, Park JJ et al. Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstruction. Gastrointest Endosc 2018;87:1548-1557.e1541.CrossRef Lee YJ, Yoon JY, Park JJ et al. Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstruction. Gastrointest Endosc 2018;87:1548-1557.e1541.CrossRef
20.
go back to reference Maruthachalam K, Lash GE, Shenton BK et al. Tumour cell dissemination following endoscopic stent insertion. Br J Surg 2007;94:1151–1154.CrossRef Maruthachalam K, Lash GE, Shenton BK et al. Tumour cell dissemination following endoscopic stent insertion. Br J Surg 2007;94:1151–1154.CrossRef
21.
go back to reference Broholm M, Kobborg M, Frostberg E et al. Delay of surgery after stent placement for resectable malignant colorectal obstruction is associated with higher risk of recurrence. Int J Colorectal Dis 2017;32:513–516.CrossRef Broholm M, Kobborg M, Frostberg E et al. Delay of surgery after stent placement for resectable malignant colorectal obstruction is associated with higher risk of recurrence. Int J Colorectal Dis 2017;32:513–516.CrossRef
22.
go back to reference Lim T, Tham HY, Yaow CYL, et al. Early surgery after bridge-to-surgery stenting for malignant bowel obstruction is associated with better oncological outcomes. Surg Endoscopy 2021 Lim T, Tham HY, Yaow CYL, et al. Early surgery after bridge-to-surgery stenting for malignant bowel obstruction is associated with better oncological outcomes. Surg Endoscopy 2021
Metadata
Title
Clinical Significance of Surgical Resection Timing from Endoscopic Stenting for Left-Sided Large-Bowel Obstruction in Colorectal Cancer
Authors
Sunseok Yoon
Guangzhe Pian
Sun Gyo Lim
Seung Yeop Oh
Publication date
04-01-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07331-5

Other articles of this Issue 10/2022

Digestive Diseases and Sciences 10/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.